Where to invest $20,000 in ASX 200 shares

Altium Limited (ASX:ALU) shares are one of three that I would invest $20,000 into this week…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With interest rates at record lows and likely to go even lower over the coming months, if I had $20,000 sitting in a savings account, I would consider putting it to work in the share market.

After all, if rates go much lower, they will fall beneath the inflation rate, which means that you could soon be making a negative real return on your savings.

With that in mind, here are three quality shares that I would consider investing $20,000 into this month:

Altium Limited (ASX: ALU)

I think that this award-winning printed circuit board (PCB) design software provider could be a great option for that $20,000 investment. This is because I believe Altium has a long runway for growth thanks to its exposure to the rapidly growing Internet of Things (IoT) market. As PCBs are found in almost all IoT devices, I expect demand for its software to continue increasing at a strong rate for a long time to come. 

Collins Foods Ltd (ASX: CKF)

Another good option for these funds could be this leading KFC, Taco Bell, and Sizzler restaurant operator. In FY 2019 Collins Foods was a strong performer, reporting a 16.9% increase in revenue and a 15.7% increase in underlying net profit of $45 million. This strong result was driven by a combination of strong same store sales growth in Australia and the expansion of its network. The good news is that I believe Collins Foods can continue this solid form thanks largely to its massive opportunity in Europe.

ResMed Inc (ASX: RMD)

Another growth share to consider investing these funds into is this medical device company. ResMed has a portfolio of cloud-connected devices which care for people with sleep apnoea, chronic obstructive pulmonary disease, and other chronic diseases. The sleep treatment market is tipped to grow strongly over the next decade, which I believe puts ResMed in a position to continue growing its earnings at an above-average rate for some time to come.

Motley Fool contributor James Mickleboro owns shares of Collins Foods Limited. The Motley Fool Australia owns shares of Altium. The Motley Fool Australia has recommended Collins Foods Limited and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

chart showing an increasing share price
Growth Shares

Buy these excellent ASX growth shares for 15% to 20% returns

Analysts think big returns could be on the cards for owners of these shares.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Growth Shares

These ASX 200 growth shares could rise 12% to 30%

Analysts think big returns could be on offer from these shares.

Read more »

Man in an office celebrates at he crosses a finish line before his colleagues.
Growth Shares

Hoping to beat the ASX 200? I'd consider buying these 3 ASX shares

Analysts think these shares can outperform the market.

Read more »

a happy investor with a wide smile points to a graph that shows an upward trending share price
Growth Shares

5 top ASX growth shares to buy in April

Analysts think growth investors should be buying these shares.

Read more »

A young woman holds her hand to her mouth in surprise as she reads something on her laptop.
Growth Shares

These mid-cap ASX shares could rise 20% to 50%

Goldman Sachs is tipping these stocks as buys.

Read more »

A happy boy with his dad dabs like a hero while his father checks his phone.
Growth Shares

2 ASX growth shares that could turn $1,000 into $10,000 by 2034

I think these two stocks have a shot at being 10-baggers.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Growth Shares

These top ASX 200 growth shares can rise 10% to 50%

Analysts see major upside ahead for these buy-rated shares.

Read more »

A young man wearing glasses writes down his stock picks in his living room.
Growth Shares

I think this ASX growth stock has market-beating potential

I'm betting that this investment will crush the ASX over the next few years.

Read more »